Fluids and barriers of the CNS

Studying and fixing blood-brain barrier problems in brain cells from children with cerebral adrenoleukodystrophy

Updated

Abstract

from patients with ccALD had significantly decreased (2592 ± 110 Ω cm) compared to WT controls (5001 ± 172 Ω cm).

  • Patients with ccALD show compromised blood-brain barrier (BBB) integrity compared to wild-type controls.
  • ccALD-iBMECs accumulate lipid droplets more than WT-iBMECs, indicating altered lipid metabolism.
  • Treatment with PEO-PPO block copolymers during differentiation improves TEER and reduces lipid accumulation in ccALD-iBMECs.
  • These findings may help identify BBB-specific molecular markers for early detection of ccALD.

Simplified

Key numbers

2592 ± 110 Ω cm
Decrease in
Compared to WT- with 5001 ± 172 Ω cm.
5.4 ± 1.0 × 10
Lipid droplet intensity
Compared to WT- with 1.8 ± 0.5 × 10.
3316 ± 246 Ω cm
improvement with EP treatment
Compared to untreated ccALD- at 2409 ± 254 Ω cm.

Full Text

What this is

  • This research investigates the blood-brain barrier (BBB) function in childhood cerebral adrenoleukodystrophy (ccALD) using ().
  • The study compares derived from ccALD patients to those from healthy controls, focusing on barrier integrity and lipid accumulation.
  • It evaluates the potential of block copolymer treatments to restore BBB function in ccALD.

Essence

  • ccALD- exhibit significantly impaired barrier integrity and increased lipid accumulation compared to WT-. Treatment with diblock copolymers improves barrier function and reduces lipid accumulation.

Key takeaways

  • ccALD- show a marked decrease in (), measuring 2592 ± 110 Ω cm vs. 5001 ± 172 Ω cm in WT-. This indicates compromised BBB integrity in ccALD patients.
  • Lipid droplet accumulation is significantly higher in ccALD-, with an average intensity of red pixels from Oil-Red-O staining at 5.4 ± 1.0 × 10 for ccALD vs. 1.8 ± 0.5 × 10 for WT. This suggests a metabolic dysfunction in ccALD.
  • Treatment with the diblock copolymer EP during differentiation increases to 3316 ± 246 Ω cm in ccALD-, compared to 2409 ± 254 Ω cm in untreated cells. This shows potential for therapeutic intervention.

Caveats

  • The study primarily focuses on one cell type (BMECs), which may limit the understanding of the complete neurovascular unit's role in ccALD pathology.
  • While the findings indicate significant differences in barrier integrity, the underlying mechanisms of how lipid accumulation affects BBB function require further investigation.

Definitions

  • Trans-endothelial electrical resistance (TEER): A measure of the electrical resistance across a cell layer, indicating barrier integrity.
  • Induced brain microvascular endothelial cells (iBMECs): Cells derived from induced pluripotent stem cells that model the blood-brain barrier.

Simplified

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free